AzTrials
AzTrials

InfectionCampus&CoronaNCT04529421

Assocation Between In-person Instruction and COVID-19 Risk

An observational study of Infection and Infection Control, run by Oslo Metropolitan University at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Whether university teaching on campus with infection control measures in place is associated with higher risk of COVID-19 than online instruction, is unknown. The investigators will assess this by conducting repeated surveys among students at universities and university colleges in Norway, where some instruction is… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Infection, Infection Control
What is being tested?
Online instruction and In-person instruction
How many people
26,754 participants
Where
1 siteNorway
Study dates
4 Sep 2020to 31 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: All university of university college students who agree to participate.

Who may be able to join

  • Student in first, second, or third year at university or university college
  • Agrees to participate (signed consent form)

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo Metropolitan University

    Oslo, 0130

Other trials in Norway

About this study

Official title: Relationship Between In-person Instruction and COVID-19 Incidence Among University Students: A Prospective Cohort Study

Whether university teaching on campus with infection control measures in place is associated with higher risk of COVID-19 than online instruction, is unknown. The investigators will assess this by conducting repeated surveys among students at universities and university colleges in Norway, where some instruction is given in-person, and some is provided online (hybrid model). The investigators will ask about the students' COVID-19 status, and how much in-person and online instruction the students are getting. The investigators will estimate the association between in-person instruction and COVID-19-risk using multivariate regression, controlling for likely confounders. The investigators will also assess whether type of instruction is associated with how satisfied the students are with the instruction the students are offered, their quality of life, and learning outcomes.

Read the detailed description

The investigators are inviting all universities and university colleges in Norway to take part. All students at institutions that agree to participate will receive an SMS (alternatively an e-mail) inviting them to take part in the study. The invitation includes a link that directs participants to a web-based informed consent-form and questionnaire. The investigators will use the University of Oslo's solutions for online consent form, web-based survey (Nettskjema), and secure storage of research data (TSD).

The investigators will ask the participants if the participants have been tested for COVID-19, the results of such a test, how much in-person instruction the students have been offered, and how much online instruction the students have been offered. The investigators will also inquire about other risk factors for COVID-19 and background variables that may be included as potential adjustment factors (confounders) in the analyses (see Attachment 1 - Questionnaire).

The investigators will survey the students every two weeks by new invitations by SMS or e-mail. The study period will last as long as the universities maintain their arrangement with in-person instruction for only select groups of students. The investigators plan for a study period that lasts for the remainder of 2020. The investigators will ask for the participants consent to link the survey results to information on study programme, basis for admission, study status, academic results, sex and age from the Common Student System.

The investigators will run multivariate regressions to test whether there is an association between in-person instruction and the outcomes.

In-person instruction is a continuous variable, defined as

(Number of days offered in-person instruction) / (Number of days offered in-person instruction + Number of days offered online instruction)

The investigators will control for potentially confounding variables, including year of study program, field of study, age, and gender. The investigators plan for separate analyses for each participating university/university college, and a pooled analysis across institutions.

Being tested
Online instruction, In-person instruction
Keywords
COVID-19, Social distancing, Digital instruction, In-person instruction, Campus, University, College, Higher education institutions
Medical subject headings
Infections, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online instructionBehavioural

    For some courses and groups of students, instruction is primarily offered digitally, so that the students can participate from outside campus.

  • In-person instructionBehavioural

    For some courses and groups of students, instruction is primarily offered in-person, on campus (or elsewhere).

Study groups in NCT04529421
Study groupRoleWhat they receive
Students, Higher Education Institution 1All first, second, and third year students at Higher Education Institution 1 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 2All first, second, and third year students at Higher Education Institution 2 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 3All first, second, and third year students at Higher Education Institution 3 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 4All first, second, and third year students at Higher Education Institution 4 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 5All first, second, and third year students atHigher Education Institution 5 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 6All first, second, and third year students at Higher Education Institution 6 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 7All first, second, and third year students at Higher Education Institution 7 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 8All first, second, and third year students at Higher Education Institution 8 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 9All first, second, and third year students at Higher Education Institution 9 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 10All first, second, and third year students at Higher Education Institution 10 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 11All first, second, and third year students at Higher Education Institution 11 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 12All first, second, and third year students at Higher Education Institution 12 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 13All first, second, and third year students at Higher Education Institution 13 who agree to take part in study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction
Students, Higher Education Institution 14All first, second, and third year students at Higer Education Institution 14 who agree to take part in the study.
Receives: Behavioral: Online instruction; Behavioral: In-person instruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. COVID-19 incidence

    Self-reported positive test results

    Measured: Through study completion, i.e. 4 months.

Secondary outcomes (4)
  1. Quality of life

    Self-reported ("Overall, how satisfied are you with life right now?")

    Measured: Through study completion, i.e. 4 months.

  2. Satisfaction with teaching

    Self-reported ("Overall, how satisfied have you been with the teaching you have received in the past 14 days?")

    Measured: Through study completion, i.e. 4 months.

  3. COVID-19 testing incidence

    Self-reported

    Measured: Through study completion, i.e. 4 months.

  4. Learning outcome

    Exam results from Common Student System

    Measured: End of term, December 2020.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2020
  2. Study start4 Sep 2020
  3. Primary completion31 Dec 2020
  4. Study completion31 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
26,754 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04529421
Sponsor's protocol ID
172155
Acronym
Campus&Corona
Status last verified
Nov 2023
First submitted
25 Aug 2020
Last updated
13 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We plan to make the full data set publicly available, after ensuring the re-identification of individuals is not possible.

Publications

  • Fretheim A, Helleve A, Loyland B, Sandbekken IH, Flato M, Telle K, Watle SV, Schjoll A, Helseth S, Jamtvedt G, Hart RK. Relationship between teaching modality and COVID-19, well-being, and teaching satisfaction (campus & corona): A cohort study among students in higher education. Public Health Pract (Oxf). 2021 Nov;2:100187. doi: 10.1016/j.puhip.2021.100187. Epub 2021 Aug 27.

    PubMed 34467258

Questions about this trial

What is this clinical trial studying?

An observational study of Infection and Infection Control, run by Oslo Metropolitan University at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

COVID-19 incidence (time frame: Through study completion, i.e. 4 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04529421, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in